683 Capital Management, LLC Madrigal Pharmaceuticals, Inc. Put Options Transaction History

683 Capital Management, LLC

  • $1.1 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$193.33 - $291.99 $32.2 Million - $48.6 Million
-166,400 Reduced 93.54%
11,500 $3.22 Million
Q1 2024

May 15, 2024
BUY
$171.37 - $283.23 $28.8 Million - $47.6 Million
167,900 Added 1679.0%
177,900 $47.5 Million
Q3 2023

Nov 14, 2023
SELL
$146.04 - $225.78 $3.65 Million - $5.64 Million
-25,000 Reduced 71.43%
10,000 $1.46 Million
Q1 2023

May 15, 2023
BUY
$231.06 - $307.08 $8.09 Million - $10.7 Million
35,000 New
35,000 $8.48 Million

Others Institutions Holding MDGL

# of Institutions
296
Shares Held
21.9M
Call Options Held
819K
Put Options Held
644K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.79B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email